Building Medtech Connections and Why They Matter
Scott Whitaker, president and CEO of AdvaMed®, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of…
Government & Legislative Affairs
Learn more about our Advocacy work.
Investments in Semiconductor Chip Manufacturing Critical for Medtech Industry, Patient Health
Today, AdvaMed® marked the one year anniversary of the signing of the bipartisan CHIPS and Science Act and called on the Biden Administration to ensure, as implementation moves forward, that…
Medtech Sterilization and Patient Care: The Critical Role of Ethylene Oxide
Ethylene oxide sterilization ensures billions of pieces of medical technology are sterile for patients in every medical setting, in surgical procedures from c-sections to knee replacements.
Coverage of Breakthrough Technologies at Center of New House Committee Hearing
This week, AdvaMed®, the Medtech Association, praised ongoing legislative efforts to develop a pathway for Medicare coverage for FDA-approved breakthrough technologies during a House Committee on Energy and Commerce Subcommittee…
Op-ed: Risk, Regulation, and Reality Checks: The Example of Ethylene Oxide
According to a senior toxicologist in a RealClearPolicy op-ed, the EPA draws unreasonable conclusions about the health risks of the ethylene oxide used to sterilize medical technology.
AdvaMed® Statement on CMS’s Proposed Rule for Breakthrough Technology Coverage
AdvaMed®, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the recently issued proposed Transitional Coverage for Emerging Technologies (TCET) rule.
AdvaMed® to CMS: “Patients Are Still Waiting—But We’re Encouraged Congress No Longer Wants to Wait”
AdvaMed®, the Medtech Association, today called on the Biden Administration to implement a proposal to create a predictable pathway to national Medicare coverage for breakthrough medical technologies. The announcement comes…
Congress Must Take Action to Protect Patient Health
It is easy to take for granted the role medtech plays in our everyday lives. From heart valves, imaging equipment, and pacemakers to continuous glucose monitors, we rely on these technologies to…
AdvaMed® Response to Senate HELP Committee Regarding Reauthorization of Pandemic All-Hazards Preparedness Act
On March 29, AdvaMed® responded to the Senate HELP Committee’s request for information on policy priorities for the reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA).
AdvaMed® Statement on Introduction of Bipartisan VALID Act
Today, AdvaMed®, the medtech association, released the following statement from President and CEO Scott Whitaker on the introduction of the bipartisan Verifying Accurate, Leading-edge IVCT Development (VALID) Act. Introduced in…